ClearBridge Investments
ROIV icon

ClearBridge Investments’s Roivant Sciences ROIV Stock Holding History

ClearBridge Investments’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$63.1M Sell
1,783,075
-222,490
-11% -$6.57M 0.05% 296
2026
Q1 		$55.6M Buy
2,005,565
+32,644
+2% +$839K 0.05% 292
2025
Q4 		$42.8M Buy
1,972,921
+141,549
+8% +$2.79M 0.03% 347
2025
Q3 		$27.7M Sell
1,831,372
-29,168
-2% -$361K 0.02% 409
2025
Q2 		$21M Hold
1,860,540
– – 0.02% 412
2025
Q1 		$18.8M Hold
1,860,540
– – 0.02% 414
2024
Q4 		$22M Buy
1,860,540
+4
+0% +$47 0.02% 425
2024
Q3 		$21.5M Hold
1,860,536
– – 0.02% 439
2024
Q2 		$19.7M Buy
1,860,536
+630,712
+51% +$6.91M 0.02% 448
2024
Q1 		$13M Buy
+1,229,824
New +$13.3M 0.01% 522

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

ClearBridge Investments's ROIV Position: Q2 2026 in Review

ClearBridge Investments reduced its Roivant Sciences (ROIV) stake by 11% in Q2 2026, selling an estimated $6.57M and leaving 1,783,075 shares worth $63.1M. The position accounts for 0.05% of the portfolio, ranked #296.

ClearBridge Investments first reported a position in ROIV in Q1 2024 and has held it in 10 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • ClearBridge Investments held 1,783,075 shares of Roivant Sciences worth $63.1M as of Q2 2026.
  • ClearBridge Investments sold 222,490 Roivant Sciences shares in Q2 2026, an estimated $6.57M.
  • Roivant Sciences made up 0.05% of ClearBridge Investments's portfolio in Q2 2026, its #296 holding.
  • ClearBridge Investments first reported a position in Roivant Sciences in Q1 2024 and has held it in 10 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on ClearBridge Investments's 13F filing for Q2 2026, filed 13 Aug 2026.